🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2007-12
Trial ID
NCT00575406
Treatments Being Tested
To evaluate the safety and efficacy of R-COMP in elderly patients with adva...
Status
Unknown
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT00244127
Treatments Being Tested
The purpose of this study is to determine how many pathological complete re...
Status
Unknown
Location
Hospital de Hospitalet
Start Date
2008-01
Trial ID
NCT00721747
Treatments Being Tested
This is a study incorporating brentuximab vedotin and dose attenuated ritux...
Status
Active Not Recruiting
Location
James P. Wilmot Cancer Institute, University of Rochester Medical Center
Start Date
2016-06
Trial ID
NCT02734771
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin and cyclophospha...
Status
Completed
Location
Centre Paul Papin
Start Date
2006-01
Trial ID
NCT00424203
Two regimen are currently considered to have highest efficacy for patients ...
Status
Completed
Location
NTC
Start Date
2014-12
Trial ID
NCT02125344
To evaluate the efficacy and safety of treatment with MYOCET® (doxorubicin ...
Status
Completed
Location
Teva Investigational Site 16
Start Date
2008-10-13
Trial ID
NCT00712881
The Phase II study proposed here assesses the hypothesis that replacing dox...
Status
Completed
Location
Hospital Universitario de Alava
Start Date
2013-10-11
Trial ID
NCT02012088
This is a phase II comparative randomized clinical trial. Eligible patient...
Status
Completed
Location
P.O. M. Bufalini
Start Date
2010-09
Trial ID
NCT01885013
Treatments Being Tested
The purpose of the study is to evaluate the benefit of adjuvant chemotherap...
Status
Completed
Location
Clinique du Sud Luxembourg
Start Date
2012-04-12
Trial ID
NCT01564056
Treatments Being Tested